Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.3 EUR | -1.84% | -0.07% | -3.46% |
03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | Other Pharmaceuticals | -0.07% | -0.07% | -3.46% | -8.92% | +8.31% | 35TCr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Charts Johnson & Johnson
- Comparison Chart